Related Experiment Videos

Effect of sodium metabisulphite on bronchial blood flow in conscious sheep: pharmacological modulation

G M Nichol1, G H Parsons, K F Chung

  • 1Department of Thoracic Medicine, Royal Brompton National Heart & Lung Hospital, London.

Insights

Sodium metabisulphite (MBS) causes bronchial vasodilation in sheep, not bronchoconstriction. This effect on bronchial blood velocity is not mediated by histamine or cholinergic pathways.

Area of Science:

  • Respiratory Physiology
  • Pharmacology

Background:

  • Sodium metabisulphite (MBS) is known to trigger bronchoconstriction in asthmatic patients.
  • The precise mechanism underlying MBS-induced respiratory effects requires further investigation.

Purpose of the Study:

  • To investigate the impact of inhaled sodium metabisulphite (MBS) aerosol on bronchial blood velocity (Vbr) and pulmonary resistance.
  • To explore the potential mediators involved in MBS-induced airway responses.

Main Methods:

  • Utilized intubated conscious sheep as a model.
  • Measured bronchial blood velocity (Vbr) using an ultrasonic Doppler flow probe.
  • Administered MBS aerosol and various antagonists (ipratropium bromide, chlorpheniramine, cimetidine, frusemide, nedocromil sodium).

Main Results:

  • Inhaled MBS caused a dose-dependent, transient increase in Vbr.
  • No significant changes were observed in aortic or pulmonary artery pressures.
  • Tachyphylaxis in Vbr response to successive MBS inhalations was noted.
  • Antagonists and anti-asthma drugs did not affect the MBS-induced Vbr increase.

Conclusions:

  • Sodium metabisulphite induces bronchial vasodilation in conscious sheep.
  • This MBS-induced vasodilation is independent of histamine release or cholinergic pathway activation.

Related Concept Videos